Scott Olson/Getty Images News
Bayer (OTCPK:BAYZF) said a jury reached a verdict in favor of Monsanto in a Roundup product liability trial in California on Friday.
A jury before Judge Patrick Palacios in the Superior Court of California, San Benito County ruled in favor of Bayer (OTCPK:BAYZF), according to a statement.
“The jury’s verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer and is not responsible for the plaintiff’s illness,” Bayer said in the statement. “The verdict continues the company’s strong record at trial, winning ten of the last fifteen cases, and validates its strategy of taking cases to trial based on the overwhelming weight of scientific and consistent worldwide regulatory support for the safety of these products.”
The court victory comes after Bayer (OTCPK:BAYZF) had recently suffered some high-profile losses in the Roundup Litigation. Last month, a Missouri jury ordered the company to pay $1.56 billion to four plaintiffs who claimed that years of Roundup use caused their non-Hodgkin’s lymphomas. In late October Monsanto unit was ordered by a California jury to pay $332 million to a plaintiff who blamed his cancer on his use of the company’s Roundup weedkiller.
On Monday a Washington jury ordered Bayer’s (OTCPK:BAYZF) Monsanto to pay $857 million to former students and parent volunteers who said they became ill after being exposed to polychlorinated biphenyls, or PCBs, that leaked from light fixtures at a school northeast of Seattle, Reuters reported, citing a lawyer for the plaintiffs.
Bayer (OTCPK:BAYRY) maintains that Roundup, including its main ingredient glyphosate, is safe and has cited multiple regulators, including the U.S. Environmental Protection Agency, to support its claims.
